NFKB1 and hepatocellular carcinoma: In a recent article, Ashour et al. (2014, 2016) demonstrated that TQ can also inhibit NF-κB phosphorylation and its regulated gene products, such as interleukin-8 and chemokines, in a dose- and time-dependent manner in hepatocellular carcinoma cells.